CUSIP 09061G101COMBMRNQ4 2025
Aggregate 13F value by quarter
Multi-quarter trend — upgrade to see history
UpgradeQ4 2025
533 funds hold this security · Q4 2025
| # | Fund | Shares | Value | Δ Shares | Activity |
|---|---|---|---|---|---|
| 1 | Blackrock, Inc. | 19.14M | $1.14B | −2.91M | Reduced |
| 2 | Vanguard Group Inc | 18.13M | $1.08B | −454.7K | Reduced |
| 3 | Dodge & Cox | 14.57M | $866.04M | −114.4K | Reduced |
| 4 | Primecap Management Co/Ca/ | 14.55M | $864.67M |
| −680.0K |
| Reduced |
| 5 | Norges Bank | 7.53M | $447.57M | +5.49M | Added |
| 6 | State Street Corp | 7.52M | $447.10M | −1.24M | Reduced |
| 7 | Aqr Capital Management LLC | 6.69M | $395.20M | +754.8K | Added |
| 8 | Viking Global Investors LP | 6.04M | $358.78M | −2.29M | Reduced |
| 9 | Geode Capital Management, LLC | 3.67M | $218.39M | +132.0K | Added |
| 10 | Dimensional Fund Advisors LP | 3.32M | $197.40M | +1.08M | Added |
See every fund holding Biomarin Pharmaceutical Inc, with full quarter-over-quarter share changes.
Unlock all holders